These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 35855861

  • 1. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
    Liu J, Ma Q, Sun Q, Luo Q, Wang Y, Wang C, Zhu A, Zhao L, Yin L, Lou J, Dong Y, Qiu P.
    Oxid Med Cell Longev; 2022; 2022():4301033. PubMed ID: 35855861
    [Abstract] [Full Text] [Related]

  • 2. Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys.
    Du L, Feng Y, Wang C, Shi X, Wen C, He Z, Zhang Y.
    J Ethnopharmacol; 2022 Nov 15; 298():115643. PubMed ID: 36031105
    [Abstract] [Full Text] [Related]

  • 3. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep 15; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 4. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 5. Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
    Ji L, Fan X, Hou X, Fu D, Bao J, Zhuang A, Chen S, Fan Y, Li R.
    Front Pharmacol; 2020 Sep 01; 11():1049. PubMed ID: 32760274
    [Abstract] [Full Text] [Related]

  • 6. Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway.
    Wu S, Ji L, Fan X, Fang S, Bao J, Yuan X, Fan Y, Xie G.
    Evid Based Complement Alternat Med; 2022 Sep 01; 2022():4987323. PubMed ID: 35591863
    [Abstract] [Full Text] [Related]

  • 7. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X.
    BMC Nephrol; 2022 Jul 08; 23(1):243. PubMed ID: 35804318
    [Abstract] [Full Text] [Related]

  • 8. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC, Wu D, Wu HL, Li HY, Yang C, Su HY, Liu ZJ, Huang XR, Lu X, Huang LF, Zhu SP, Pan QJ, An N, Liu HF.
    Lupus Sci Med; 2022 Apr 08; 9(1):. PubMed ID: 35414608
    [Abstract] [Full Text] [Related]

  • 9. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q, Yang C, Wang Q, Zeng H, Qin W.
    PLoS One; 2015 Apr 08; 10(7):e0133724. PubMed ID: 26208003
    [Abstract] [Full Text] [Related]

  • 10. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
    Ji LN, Wu S, Fu DQ, Fang SJ, Xie GQ, Fan YS, Bao J.
    J Ethnopharmacol; 2022 Feb 10; 284():114815. PubMed ID: 34763039
    [Abstract] [Full Text] [Related]

  • 11. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X, Wang M, Hong H, Luo C, Liu Z, Yang R.
    Immunol Res; 2018 Aug 10; 66(4):521-527. PubMed ID: 30047025
    [Abstract] [Full Text] [Related]

  • 12. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B, Xia W, Wen C, Ding X.
    J Nat Med; 2015 Jul 10; 69(3):349-57. PubMed ID: 25821132
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Jul 10; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 14. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
    Sun J, Guo S, Niu F, Liu D, Zhuang Y.
    Mol Med Rep; 2020 Dec 10; 22(6):5436-5443. PubMed ID: 33173997
    [Abstract] [Full Text] [Related]

  • 15. Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus.
    Lian F, Wang Y, Chen J, Xu H, Yang X, Liang L, Zhan Z, Ye Y, Chen M.
    Rheumatol Int; 2012 Jun 10; 32(6):1705-10. PubMed ID: 21431940
    [Abstract] [Full Text] [Related]

  • 16. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ T cells via miR-29b-sp1/DNMT1 pathway in MRL/lpr mice.
    Huang S, Peng J, Gan Y, Chen L, Zhu Z, Tian F, Ji L, Fan Y, Zhou C, Bao J.
    J Ethnopharmacol; 2023 Dec 05; 317():116776. PubMed ID: 37343653
    [Abstract] [Full Text] [Related]

  • 17. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
    Zhai JX, Zhang ZX, Feng YJ, Ding SS, Wang XH, Zou LW, Ye DQ.
    Mol Biol Rep; 2012 Jun 05; 39(6):6763-71. PubMed ID: 22318546
    [Abstract] [Full Text] [Related]

  • 18. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H, Zhao J, Wang S, Zhang L, Wang H, Huang B, Liang Y, Yu X, Yang N.
    Int Immunopharmacol; 2012 Dec 05; 14(4):401-9. PubMed ID: 22922317
    [Abstract] [Full Text] [Related]

  • 19. Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.
    Ji L, Hou X, Deng X, Fan X, Zhuang A, Zhang X, Li R.
    Evid Based Complement Alternat Med; 2019 Dec 05; 2019():2357217. PubMed ID: 31781262
    [Abstract] [Full Text] [Related]

  • 20. STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating TBK1 and activating NF-κB signal pathway.
    Chen J, Chen P, Song Y, Wei J, Wu F, Sun J, Xu Z.
    J Biosci; 2024 Dec 05; 49():. PubMed ID: 38186000
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.